Editor’s Note: As Chief Investment Strategist of Total Wealth, Keith believes in making his track record of recommendations easily accessible to all readers within seconds – and that’s why he’s compiled an Archives page. Here you’ll find links to every Total Wealth article Keith has published since Total Wealth’s creation on October 2, 2014, posted in reverse chronological order.
Category: Unstoppable Trends
Filter by Date:
Earlier this year, I told you about a small, relatively unheard of media company poised for profits-no matter what kind of agenda our next president brings to the White House. So far, it’s beaten the S&P by a little more than 2 to 1, and returned 28% to date versus only 12% from the S&P 500 over the same time frame.
If you’re on board, that’s fabulous. Chances are, you’re grinning ear to ear for having made your move. If not, you’ll want to act quickly.
You see, all the political discord, the name-calling, and the finger-pointing that’s taken over our airwaves at the moment actually improves this company’s potential.
May 09, 2016
As the presumptive GOP nominee, it’s time for Donald Trump to tackle the sophisticated issues. As Trump takes his seat at the ‘big boy table,’ what does his tax agenda mean for your money?
I’ve got some important news today regarding our favorite Human Augmentation play: Ekso Bionics Holdings Inc. (OTCQB:EKSO).
The company made a major announcement earlier this week that’s proof positive Ekso is on track and progressing nicely as expected. It’s also something I’m extremely excited to see, for reasons I’ll tell you about in a minute.
But first, I want to start by telling you what’s happened and what it means for your money.
Washington’s made a huge stink about our economic recovery and politicians of all stripes want us to believe that their actions are in the name of your financial prosperity.
What a load of you-know-what.
I’m not going to mince words – our government is killing the American Dream and, with it, the retirement hopes of millions of investors.
Thankfully, though, not yours.
Today we’re going to talk about why the U.S. government’s latest boneheaded move actually clears the path for bigger profits, and how you’ll know what to buy both now and in the future when you see them repeat their mistakes.
Apple Inc. (NasdaqGS:AAPL) took a beating last week, shedding more than 7% of its market cap as Carl Icahn made a bad selloff worse by unloading $700 million worth of stock. Here’s why individual investors shouldn’t follow Icahn’s example.
I’m used to giving tough presentations, but last week’s took the cake when I was asked to frame my delivery around something that’s on many investors’ minds at the moment…
…how to invest for big profits when the smartest guys in the room are wrong
There’s no doubt the “guys in the room are wrong” when you look at the mess central bankers around the world have created in their rush to stimulate the world’s economy.
Nearly every central banker around the world has his or her hands in the proverbial cookie jar at the moment. Together they’ve injected an estimated $8 trillion into the world’s markets with more on the way according to The Wall Street Journal. Yet, the IMF recently made headlines for downgrading global growth to a mere 3.2%??!!
If central bankers actually knew what they were doing and stimulus actually worked, the world’s economy would be screaming along at 7% a year and there’d be more jobs than workers. Wages would be rising and there’d be a housing market that would make even the Kardashians blink.
That’s obviously not happening. Trying the same tired old tactics and expecting different results is a fool’s errand. And that means you’ve got to invest accordingly.
That’s what we’re going to talk about today and, as always, I’ve got an investment choice to get you started that’s perfectly suited for today’s markets.
If you remember the early 1980s like I do, chances are you remember the driving base line, electrifying sound and scorching vocals of this smash hit performed by the British rock band, Queen.
An ode to the times, it came to symbolize any key event that doesn’t go ahead as planned or an unanticipated outcome from which there is no potential recovery.
Like the long anticipated Pfizer/Allergan tie up.
That deal came to an unceremonious end earlier this week when the country’s biggest drug company walked away from a $160 billion deal that would have relocated the company to Ireland as a means of lowering taxes.
The term “human augmentation” brings to mind nightmarish sci-fi movie images for many people. But it brings to mind dollar signs for me.
That’s because the industry will grow by more than 4,000% in the next four years, to total $1.8 billion by 2020.
However, not all that growth will happen equally.
You’ve got to make some very careful decisions when it comes to your money if you want to line up with the winners. The vast majority of emerging tech in this area will never make it off the drawing board, let alone into production. Clearly, not all stocks are equal.
Here’s the thing most investors are missing.
The winners aren’t just developing new technology; they’re developing it in such a way that they’ve got access to entirely new business models competitors don’t understand or simply cannot access.
That’s why I’m excited to tell you about the latest headline making news from our favorite Human Augmentation play, Ekso Bionics Holdings Inc. (OTC:EKSO).
What I’m about to tell you gives the company a distinct advantage and could create an entirely new group of millionaires savvy enough to cash in.
Michael Burry has time for just one investment these days.
The doctor-turned-fund manager, best known for his depiction in the Oscar-nominated movie “The Big Short,” was already a legend in investing circles for his tenure at Scion Capital, where he beat the market by 96 to 1 from 2000-2008 and oversaw record returns of more than 480%.
In the January box-office smash hit, Burry’s character claims that shorting the housing market was an investment play based on “a certainty.”
Fast forward to today.
Like you, I woke up Tuesday morning to horrific news of twin terrorist attacks at the Brussels Airport and the Maelbreek Metro Station that have killed at least 34 and wounded hundreds more. My heart is heavier than I can convey as I think about the lives savagely cut short.
Still, the world will go on.
Whatever we wish would be the case, War, Terrorism, & Ugliness is not going to go away any time soon. Unfortunately, all three are “growth industries” at the moment, and that means every investor needs to understand how to navigate his or her money through a world that will be increasingly shaped by terrorism.
Admittedly, that sounds callous. But, I learned something during the 2011 Tohoku Earthquake and Tsunami that helps me keep things in perspective – the best way to honor those who have perished is to redouble your efforts to live fully and to the best of your abilities.
Quick… how many Comcast technicians does it take to fix a DVR?
Eight, evidently… and my DVR is still not working after five weeks of calling offshore customer service centers, visiting technicians who are guaranteed to arrive within a “two hour window,” and even the company’s executive resolution team.
Sadly, my predicament isn’t unusual and there’s no way I’d recommend investing in the company as a result. There are thousands of companies who claim to be all about their customers when, in fact, their customers might as well be an inconvenience based on how they’re treated.
I’m sharing my predicament with you for a reason – buying “what you know” used to be a fundamental underpinning of investment success. Now, it’s a recipe for disaster.
We’re going to talk about that today and, as always, I’m going to highlight a company where customers are truly the most important part of their business.
It’s a distinction that’s helped this company outperform the S&P 500 by 5 to 1 and led to returns 100 times greater than those achieved by Comcast – a popular investment choice – over roughly the same time frame.
One of Wall Street’s cardinal sins is a “set it and forget it” mentality. What I mean by that is there’s often a flurry of interest in specific stocks and then….nothing.
That’s too bad because the devil, as they say, is always in the details.
As we have discussed many times here at Total Wealth, you’ve got to check in on what you own periodically to ensure a given stock, bond, or ETF: a) still meets your objectives and risk tolerance, and b) that the reasons you bought it are still valid.
I call this the “ultimate trailing stop” simply because you want to make sure you’re on track not just when you buy something, but every day you own it.
No doubt you’re following America’s Presidential Election closely – even if you’d rather not.
As investors, we have no choice but to monitor one of the most consequential races in American history. Entire sectors hang in the balance: defense, health, technology, housing, manufacturing… you name it.
The next President of the United States will dramatically shape the stock market.
My job is to make sure you’re among the winners, and that your portfolio thrives no matter what agenda our next president brings to the White House.
And, trust me, there will be an agenda.
That’s your opportunity.
The small-cap company I’ve found could return 420% or more by the time the election ballots are counted.
I’ve reviewed thousands of companies over the past 33 years in global markets, but none capture the imagination the way Ekso Bionics Holdings Inc. (OTC:EKSO) does.
The tiny exoskeleton maker just reported earnings and, as you might expect, there’s broad-based growth in every metric that matters from revenue, to staffing, to new contracts, overseas expansion. You name it.
But there’s something the media isn’t covering.
Ironically, it’s the single most important factor in what I believe will ultimately be an exceptionally bright future for the company and savvy investors alike.
Here’s why there’s more upside for Ekso than any analyst will tell you.